PDB Short entry for 2ETM HEADER TRANSFERASE 27-OCT-05 2ETM TITLE CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H- TITLE 2 PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FADK 1, PP125FAK, PROTEIN- TYROSINE KINASE 2; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2, FAK, FAK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBACHTB KEYWDS KINASE CATALYTIC DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.C.LEE REVDAT 3 23-AUG-23 2ETM 1 REMARK SEQADV REVDAT 2 24-FEB-09 2ETM 1 VERSN REVDAT 1 10-OCT-06 2ETM 0 JRNL AUTH C.B.ANDERSEN,K.NG,C.VU,S.FICARRO,H.-S.CHOI,N.GRAY,Y.HE, JRNL AUTH 2 C.C.LEE JRNL TITL CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED JRNL TITL 2 WITH ATP AND NOVEL 7H-PYRROLO [2,3-D] PYRIMIDINE SCAFFOLDS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 25328 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4225 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.596 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ETM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035076. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 200.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25328 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 6.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 4.050 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : 0.06600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JPA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG-600, 10% GLYCEROL, HEPES REMARK 280 PH 7.5, 0.05M LI2SO4 , VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 409 REMARK 465 ALA A 410 REMARK 465 SER A 411 REMARK 465 THR A 412 REMARK 465 ARG A 413 REMARK 465 ASP A 414 REMARK 465 ASP A 573 REMARK 465 SER A 574 REMARK 465 THR A 575 REMARK 465 TYR A 576 REMARK 465 TYR A 577 REMARK 465 LYS A 578 REMARK 465 ALA A 579 REMARK 465 SER A 580 REMARK 465 LYS A 581 REMARK 465 GLY A 582 REMARK 465 GLN A 687 REMARK 465 GLU A 688 REMARK 465 GLU A 689 REMARK 465 GLY B 409 REMARK 465 ALA B 410 REMARK 465 SER B 411 REMARK 465 THR B 412 REMARK 465 TYR B 570 REMARK 465 MET B 571 REMARK 465 GLU B 572 REMARK 465 ASP B 573 REMARK 465 SER B 574 REMARK 465 THR B 575 REMARK 465 TYR B 576 REMARK 465 TYR B 577 REMARK 465 LYS B 578 REMARK 465 ALA B 579 REMARK 465 SER B 580 REMARK 465 LYS B 581 REMARK 465 GLY B 582 REMARK 465 LYS B 583 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 569 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 420 -19.20 -48.51 REMARK 500 PRO A 444 -113.35 -15.21 REMARK 500 GLU A 445 18.23 -58.89 REMARK 500 SER A 463 -72.00 -45.30 REMARK 500 GLU A 492 -89.71 -77.04 REMARK 500 ASN A 493 137.97 173.55 REMARK 500 GLU A 500 150.09 -37.42 REMARK 500 ARG A 545 -20.82 98.34 REMARK 500 LEU A 567 74.89 51.22 REMARK 500 ASN A 628 -74.08 -39.52 REMARK 500 ASN A 629 -36.19 -30.51 REMARK 500 LYS A 684 -71.36 -67.30 REMARK 500 ASP B 414 2.67 31.97 REMARK 500 ARG B 426 115.47 103.20 REMARK 500 SER B 443 119.54 -39.40 REMARK 500 ALA B 448 130.06 -38.58 REMARK 500 CYS B 459 29.10 -63.60 REMARK 500 ALA B 521 -33.02 -39.70 REMARK 500 ARG B 545 -15.70 89.97 REMARK 500 CYS B 559 109.09 -162.94 REMARK 500 ASP B 564 64.69 60.14 REMARK 500 PRO B 585 49.29 -74.96 REMARK 500 GLU B 636 10.93 -69.60 REMARK 500 TRP B 659 37.73 -96.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PY A 131 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PY B 132 DBREF 2ETM A 411 689 UNP Q05397 FAK1_HUMAN 411 689 DBREF 2ETM B 411 689 UNP Q05397 FAK1_HUMAN 411 689 SEQADV 2ETM GLY A 409 UNP Q05397 CLONING ARTIFACT SEQADV 2ETM ALA A 410 UNP Q05397 CLONING ARTIFACT SEQADV 2ETM GLY B 409 UNP Q05397 CLONING ARTIFACT SEQADV 2ETM ALA B 410 UNP Q05397 CLONING ARTIFACT SEQRES 1 A 281 GLY ALA SER THR ARG ASP TYR GLU ILE GLN ARG GLU ARG SEQRES 2 A 281 ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE GLY SEQRES 3 A 281 ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN PRO SEQRES 4 A 281 ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS THR SEQRES 5 A 281 SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA LEU SEQRES 6 A 281 THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS LEU SEQRES 7 A 281 ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE MET SEQRES 8 A 281 GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU GLN SEQRES 9 A 281 VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE LEU SEQRES 10 A 281 TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU GLU SEQRES 11 A 281 SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG ASN SEQRES 12 A 281 VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY ASP SEQRES 13 A 281 PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR TYR SEQRES 14 A 281 LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET ALA SEQRES 15 A 281 PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SER SEQRES 16 A 281 ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE LEU SEQRES 17 A 281 MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN ASN SEQRES 18 A 281 ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU PRO SEQRES 19 A 281 MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU MET SEQRES 20 A 281 THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO ARG SEQRES 21 A 281 PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU GLU SEQRES 22 A 281 GLU GLU LYS ALA GLN GLN GLU GLU SEQRES 1 B 281 GLY ALA SER THR ARG ASP TYR GLU ILE GLN ARG GLU ARG SEQRES 2 B 281 ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE GLY SEQRES 3 B 281 ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN PRO SEQRES 4 B 281 ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS THR SEQRES 5 B 281 SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA LEU SEQRES 6 B 281 THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS LEU SEQRES 7 B 281 ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE MET SEQRES 8 B 281 GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU GLN SEQRES 9 B 281 VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE LEU SEQRES 10 B 281 TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU GLU SEQRES 11 B 281 SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG ASN SEQRES 12 B 281 VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY ASP SEQRES 13 B 281 PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR TYR SEQRES 14 B 281 LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET ALA SEQRES 15 B 281 PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SER SEQRES 16 B 281 ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE LEU SEQRES 17 B 281 MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN ASN SEQRES 18 B 281 ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU PRO SEQRES 19 B 281 MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU MET SEQRES 20 B 281 THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO ARG SEQRES 21 B 281 PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU GLU SEQRES 22 B 281 GLU GLU LYS ALA GLN GLN GLU GLU HET 7PY A 131 28 HET 7PY B 132 28 HETNAM 7PY 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2, HETNAM 2 7PY 3-D]PYRIMIDIN-2-AMINE FORMUL 3 7PY 2(C20 H19 N5 O3) FORMUL 5 HOH *119(H2 O) HELIX 1 1 GLN A 418 GLU A 420 5 3 HELIX 2 2 SER A 461 ARG A 476 1 16 HELIX 3 3 GLU A 506 ARG A 514 1 9 HELIX 4 4 LYS A 515 LEU A 518 5 4 HELIX 5 5 ASP A 519 SER A 539 1 21 HELIX 6 6 ALA A 548 ARG A 550 5 3 HELIX 7 7 LEU A 567 MET A 571 5 5 HELIX 8 8 ALA A 590 ARG A 597 1 8 HELIX 9 9 THR A 600 MET A 617 1 18 HELIX 10 10 LYS A 627 GLU A 636 1 10 HELIX 11 11 PRO A 648 TRP A 659 1 12 HELIX 12 12 ASP A 662 ARG A 666 5 5 HELIX 13 13 ARG A 668 ALA A 685 1 18 HELIX 14 14 GLN B 418 GLU B 420 5 3 HELIX 15 15 SER B 461 ARG B 476 1 16 HELIX 16 16 GLU B 506 ARG B 514 1 9 HELIX 17 17 ASP B 519 SER B 539 1 21 HELIX 18 18 ALA B 548 ARG B 550 5 3 HELIX 19 19 ALA B 590 ARG B 597 1 8 HELIX 20 20 THR B 600 MET B 617 1 18 HELIX 21 21 LYS B 627 GLU B 636 1 10 HELIX 22 22 PRO B 648 TRP B 659 1 12 HELIX 23 23 ASP B 662 ARG B 666 5 5 HELIX 24 24 ARG B 668 GLU B 688 1 21 SHEET 1 A 5 ILE A 422 GLU A 430 0 SHEET 2 A 5 ASP A 435 TYR A 441 -1 O VAL A 436 N ILE A 428 SHEET 3 A 5 LEU A 449 THR A 455 -1 O LEU A 449 N TYR A 441 SHEET 4 A 5 TRP A 496 GLU A 500 -1 O MET A 499 N ALA A 452 SHEET 5 A 5 LEU A 486 ILE A 490 -1 N ILE A 490 O TRP A 496 SHEET 1 B 2 VAL A 552 SER A 556 0 SHEET 2 B 2 CYS A 559 LEU A 562 -1 O CYS A 559 N SER A 555 SHEET 1 C 5 ILE B 422 GLU B 423 0 SHEET 2 C 5 ILE B 440 TYR B 441 -1 O ILE B 440 N GLU B 423 SHEET 3 C 5 LEU B 449 THR B 455 -1 O LEU B 449 N TYR B 441 SHEET 4 C 5 ASP B 435 HIS B 437 -1 N HIS B 437 O ILE B 453 SHEET 5 C 5 CYS B 427 GLU B 430 -1 N GLY B 429 O VAL B 436 SHEET 1 D 5 ILE B 422 GLU B 423 0 SHEET 2 D 5 ILE B 440 TYR B 441 -1 O ILE B 440 N GLU B 423 SHEET 3 D 5 LEU B 449 THR B 455 -1 O LEU B 449 N TYR B 441 SHEET 4 D 5 TRP B 496 GLU B 500 -1 O ILE B 497 N LYS B 454 SHEET 5 D 5 LEU B 486 ILE B 490 -1 N GLY B 488 O ILE B 498 SHEET 1 E 2 VAL B 552 SER B 556 0 SHEET 2 E 2 CYS B 559 LEU B 562 -1 O LYS B 561 N LEU B 553 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.03 SSBOND 2 CYS B 456 CYS B 459 1555 1555 2.03 CISPEP 1 ASN A 493 PRO A 494 0 -0.19 CISPEP 2 ASN B 493 PRO B 494 0 -0.17 SITE 1 AC1 10 ILE A 428 VAL A 436 ALA A 452 LYS A 454 SITE 2 AC1 10 GLU A 500 LEU A 501 CYS A 502 THR A 503 SITE 3 AC1 10 GLY A 505 LEU A 553 SITE 1 AC2 11 HOH B 55 ILE B 428 GLU B 430 VAL B 436 SITE 2 AC2 11 ALA B 452 GLU B 500 LEU B 501 CYS B 502 SITE 3 AC2 11 THR B 503 GLY B 505 LEU B 553 CRYST1 45.700 51.919 66.884 100.08 103.94 90.17 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021882 0.000065 0.005535 0.00000 SCALE2 0.000000 0.019261 0.003546 0.00000 SCALE3 0.000000 0.000000 0.015664 0.00000